Research · Sep 3, 2026
[EMN] Eastman Chemical Thesis 2026: Methanolysis Circular Drives Specialty Plastics Capital Return
Eastman Chemical Company (NYSE: EMN) FY2025 revenue ~$9.30-9.65B (-1-3%) with adj. EPS ~$7.65-8.10 reflecting continued post-2024 ~$9.30-9.65B aggregate Specialty Chemicals revenue (~$3.50-3.65B aggregate Additives & Functional Products + ~$2.55-2.70B aggregate Advanced Materials + ~$2.30-2.45B aggregate Chemical Intermediates + ~$0.95-1.05B aggregate Fibers) under continued Chairman + CEO Mark Costa since 2014 (~11-year tenure as Eastman CEO; selected post-2014 succeeded Jim Rogers retirement). One of the largest US specialty Chemicals companies. Founded 1920 as Tennessee Eastman Corporation by George Eastman as Eastman Kodak photographic chemicals subsidiary in Kingsport Tennessee (~105-year heritage; selected pioneer specialty Chemicals; selected post-1994 spin-off from Eastman Kodak); selected post-1994 NYSE listing via Eastman Kodak spin-off; selected post-1995-2025 ~$10B+ aggregate cumulative tuck-in M&A platform expansion (Solutia 2012 $4.7B + Knowlton Specialty Papers 2013 + Acetate Tow); selected post-2014 Mark Costa CEO appointment; selected post-October 2023 ~$1.0B+ Kingsport Tennessee #1 Methanolysis Plant commercial production (~110,000 tonne aggregate annual capacity); selected continued post-2025 announced ~$1.4B+ Texas + Normandy France Methanolysis Plants pipeline. Headquartered in Kingsport Tennessee; ~14,000-15,000 employees globally with global Specialty Chemicals + Advanced Materials + Methanolysis Circular Recycling manufacturing footprint. Four primary segments: Additives & Functional Products ~38%+ ($3.50-3.65B), Advanced Materials ~28%+ ($2.55-2.70B), Chemical Intermediates ~24% ($2.30-2.45B), Fibers ~10% ($0.95-1.05B). Geographic mix: North America ~50%+ + Europe + Middle East + Africa ~25% + Asia Pacific ~20% + Latin America ~5%. Methanolysis Circular Recycling pipeline (~$0.5B+ revenue ramp): selected continued post-October 2023 ~$1.0B+ Kingsport Tennessee #1 Methanolysis Plant commercial production (~110,000 tonne); selected continued post-2025 ~$1.4B+ Texas + Normandy France Methanolysis Plants pipeline (~110,000 + 160,000 tonne); selected ~$0.5-0.6B aggregate annual Methanolysis circular revenue; selected ~3x aggregate price premium vs. virgin PET; selected primary brand offtakes (Pepsi + Estée Lauder + LVMH + Procter & Gamble + Unilever). Specialty Plastics + Advanced Materials + Additives pipeline: selected continued post-2014-2025 Tritan + Cristal + Saflex + selected various aggregate specialty copolyester + ~$2.55-2.70B Advanced Materials revenue (Tritan Renew + Cristal + Saflex laminated glass interlayers); selected ~$3.50-3.65B Additives & Functional Products revenue (Coatings + Adhesives + Tires + Personal Care); selected ~$0.95-1.05B Fibers revenue (Naia + Avra + Cigarette Filter Tow). Chairman + CEO Mark Costa since 2014 (~11-year tenure); CFO William McLain. Capital position: ~$3.34 aggregate annual dividend (~42%+ aggregate payout ratio; ~3.2-3.7% aggregate dividend yield); ~$200-300M aggregate FY2025 buybacks; aggregate capital return ~$575-700M FY2025; net leverage ~2.5-3.0x Net Debt/EBITDA; investment-grade Baa2/BBB credit rating; ~115-118M diluted shares; weighted average debt maturity ~9-10 years. FY2026 thesis: Methanolysis Circular Recycling pipeline + Specialty Plastics + Advanced Materials + Additives & Functional Products pipeline + ~$1.4B+ Texas + Normandy France Methanolysis pipeline + Kingsport #1 commercial production + ~3x aggregate price premium vs. virgin PET. Risks: Dow + LyondellBasell + Celanese + DuPont + 3M + Arkema + SABIC + Indorama + Loop Industries + PureCycle Technologies + Carbios competitive displacement + Coatings + Adhesives + Tires + Personal Care end-market cycle considerations + cigarette industry decline considerations + Texas + Normandy France Capex execution considerations.